NCT00001603
- Conditions
- Behavior, Carcinoma, Carcinoma, Squamous Cell, +24 more
- Locations
-
- National Institute on Deafness and Other Communication Disorders (NIDCD) Bethesda, Maryland, United States
Clinical trial condition
Carcinoma, Squamous Cell
Explore clinical trials studying Carcinoma, Squamous Cell. Study availability and eligibility vary by location and protocol.
409 public trials
83 recruiting studies
Carcinoma, Squamous Cell trial results
Completed
Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck
NCT00195299
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +4 more
- Locations
-
- Shreveport, Louisiana, United States
NCT00539630
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +3 more
- Locations
-
- Sanofi-Aventis Seoul, South Korea
Completed
Study the Expression of Annexin A1 and Its Potential Usage as a Prognostic Marker in Oral Cancer
NCT00364715
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +4 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
NCT00042679
- Conditions
- Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +15 more
- Locations
-
- Bakersfield, California, United States
- Berkeley, California, United States
- Torrance, California, United States
- Miami Beach, Florida, United States
NCT00175643
- Conditions
- Actinic Keratoses, Carcinoma, Carcinoma, Squamous Cell, +9 more
- Locations
-
- Clinical Trials Unit, Skin Care Centre, UBC Dermatology Vancouver, British Columbia, Canada
NCT00201383
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +5 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
NCT00201279
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +5 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan
Active, Not Recruiting
A Community-based Educational Initiative to Raise Awareness of Melanoma and Other Skin Cancers.
NCT07177638
- Conditions
- Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, +16 more
- Locations
-
- Jewish Community House of Bensonhurst Brooklyn, New York, United States
Active, Not Recruiting
Neoadjuvant Study of PD-1 Inhibitor Pembrolizumab in PD-1 Naive Cutaneous Squamous Cell Carcinoma (cSCC)
NCT04808999
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +4 more
- Locations
-
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States